236 related articles for article (PubMed ID: 30125602)
1. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
Barve A; Casson L; Krem M; Wunderlich M; Mulloy JC; Beverly LJ
Exp Hematol; 2018 Nov; 67():18-31. PubMed ID: 30125602
[TBL] [Abstract][Full Text] [Related]
2. Improved multilineage human hematopoietic reconstitution and function in NSGS mice.
Wunderlich M; Chou FS; Sexton C; Presicce P; Chougnet CA; Aliberti J; Mulloy JC
PLoS One; 2018; 13(12):e0209034. PubMed ID: 30540841
[TBL] [Abstract][Full Text] [Related]
3. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
[TBL] [Abstract][Full Text] [Related]
4. Improved chemotherapy modeling with RAG-based immune deficient mice.
Wunderlich M; Manning N; Sexton C; Sabulski A; Byerly L; O'Brien E; Perentesis JP; Mizukawa B; Mulloy JC
PLoS One; 2019; 14(11):e0225532. PubMed ID: 31747424
[TBL] [Abstract][Full Text] [Related]
5. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
6. Improved B cell development in humanized NOD
Jangalwe S; Shultz LD; Mathew A; Brehm MA
Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
[TBL] [Abstract][Full Text] [Related]
7. [Generation of a new strain of NOD/SCID/IL2Rγ
Liu YC; Chen Q; Yang XL; Tang QS; Yao KT; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):639-646. PubMed ID: 29997084
[TBL] [Abstract][Full Text] [Related]
8. Pathology of macrophage activation syndrome in humanized NSGS mice.
Tarrant JC; Binder ZA; Bugatti M; Vermi W; van den Oord J; Ranieri B; Assenmacher CA; Hoepp N; O'Rourke DM; Shan X; Danet-Desnoyers G; Radaelli E
Res Vet Sci; 2021 Jan; 134():137-146. PubMed ID: 33383491
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
Bergstrom D; Leyton JV; Zereshkian A; Chan C; Cai Z; Reilly RM
Nucl Med Biol; 2016 Oct; 43(10):635-41. PubMed ID: 27497632
[TBL] [Abstract][Full Text] [Related]
10. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
11. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
[TBL] [Abstract][Full Text] [Related]
12. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.
Coughlan AM; Harmon C; Whelan S; O'Brien EC; O'Reilly VP; Crotty P; Kelly P; Ryan M; Hickey FB; O'Farrelly C; Little MA
Stem Cells Dev; 2016 Apr; 25(7):530-41. PubMed ID: 26879149
[TBL] [Abstract][Full Text] [Related]
13. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
14. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA
Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207
[TBL] [Abstract][Full Text] [Related]
15. Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells.
Hasgur S; Aryee KE; Shultz LD; Greiner DL; Brehm MA
Methods Mol Biol; 2016; 1438():67-78. PubMed ID: 27150084
[TBL] [Abstract][Full Text] [Related]
16. Development of Teratocarcinomas and Teratomas in Severely Immunodeficient NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/Szj (NSG) Mice.
Lim CY; Solter D; Knowles BB; Damjanov I
Stem Cells Dev; 2015 Jul; 24(13):1515-20. PubMed ID: 25897827
[TBL] [Abstract][Full Text] [Related]
17. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
18. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
Feuring-Buske M; Frankel A; Gerhard B; Hogge D
Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
[TBL] [Abstract][Full Text] [Related]
19. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes.
Bock TA; Orlic D; Dunbar CE; Broxmeyer HE; Bodine DM
J Exp Med; 1995 Dec; 182(6):2037-43. PubMed ID: 7500049
[TBL] [Abstract][Full Text] [Related]
20. A novel clinically relevant graft-versus-leukemia model in humanized mice.
Jia B; Zhao C; Bayerl M; Shike H; Claxton DF; Ehmann WC; Mineishi S; Schell TD; Zheng P; Zhang Y; Shultz LD; Prabhu KS; Paulson RF; Zheng H
J Leukoc Biol; 2022 Feb; 111(2):427-437. PubMed ID: 34057741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]